Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancer

BACKGROUND: CYP2D6 is a critical enzyme in the metabolism of tamoxifen and potentially a key determinant in breast cancer outcomes. Our study examined patients' beliefs about how CYP2D6 genotype would affect their prognoses. METHODS: Women enrolled in a pharmacogenomic clinical trial and on tam...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Brewer, Noel T., DeFrank, Jessica T., Chiu, Wing K., Ibrahim, Joseph G., Walko, Christine M., Rubin, Peter, Olajide, Oludamilola A., Moore, Susan G., Raab, Rachael E., Carrizosa, Daniel R., Corso, Steven W., Schwartz, Garry, Peppercorn, Jeffrey M., McLeod, Howard L., Carey, Lisa A., Irvin, William J.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2014
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058990/
https://ncbi.nlm.nih.gov/pubmed/24457521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000356565
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन